{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:35:07Z","timestamp":1791200107283,"version":"4.2.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,7]],"date-time":"2008-11-07T00:00:00Z","timestamp":1226016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum Genet"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00439-008-0585-6","type":"journal-article","created":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T05:11:27Z","timestamp":1225948287000},"page":"615-623","source":"Crossref","is-referenced-by-count":25,"title":["A novel hypomorphic MECP2 point mutation is associated with a neuropsychiatric phenotype"],"prefix":"10.1007","volume":"124","author":[{"given":"Abidemi A.","family":"Adegbola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine M.","family":"LaSalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,7]]},"reference":[{"key":"585_CR1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1531-8249(200005)47:5<670::AID-ANA20>3.0.CO;2-F","volume":"47","author":"RE Amir","year":"2000","unstructured":"Amir RE, Van den Veyver IB, Schultz R, Malicki DM, Tran CQ, Dahle EJ, Philippi A, Timar L, Percy AK, Motil KJ, Lichtarge O, Smith EO, Glaze DG, Zoghbi HY (2000) Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 47:670\u2013679","journal-title":"Ann Neurol"},{"key":"585_CR2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jmg.2006.045260","volume":"44","author":"H Archer","year":"2007","unstructured":"Archer H, Evans J, Leonard H, Colvin L, Ravine D, Christodoulou J, Williamson S, Charman T, Bailey ME, Sampson J, de Klerk N, Clarke A (2007) Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation. J Med Genet 44:148\u2013152","journal-title":"J Med Genet"},{"key":"585_CR3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1212\/WNL.56.5.611","volume":"56","author":"M Auranen","year":"2001","unstructured":"Auranen M, Vanhala R, Vosman M, Levander M, Varilo T, Hietala M, Riikonen R, Peltonen L, J\u00e4rvel\u00e4 I (2001) MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features. Neurology 56:611\u2013617","journal-title":"Neurology"},{"key":"585_CR4","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1021\/bi0001271","volume":"39","author":"E Ballestar","year":"2000","unstructured":"Ballestar E, Yusufzai TM, Wolffe AP (2000) Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry 39:7100\u20137106","journal-title":"Biochemistry"},{"key":"585_CR5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0883073807307077","volume":"23","author":"X Bao","year":"2008","unstructured":"Bao X, Jiang S, Song F, Pan H, Li M, Wu XR (2008) X chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype. J Child Neurol 23:22\u201325","journal-title":"J Child Neurol"},{"key":"585_CR6","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1212\/01.wnl.0000304752.50773.ec","volume":"70","author":"A Bebbington","year":"2008","unstructured":"Bebbington A, Anderson A, Ravine D, Fyfe S, Pineda M, de Klerk N, Ben-Zeev B, Yatawara N, Percy A, Kaufmann WE, Leonard H (2008) Investigating genotype\u2013phenotype relationships in Rett syndrome using an international data set. Neurology 70:868\u2013875","journal-title":"Neurology"},{"key":"585_CR7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.1153252","volume":"320","author":"M Chahrour","year":"2008","unstructured":"Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320:1224\u20131229","journal-title":"Science"},{"key":"585_CR8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.ejhg.5201471","volume":"13","author":"T Charman","year":"2005","unstructured":"Charman T, Neilson TC, Mash V, Archer H, Gardiner MT, Knudsen GP, McDonnell A, Perry J, Whatley SD, Bunyan DJ, Ravn K, Mount RH, Hastings RP, Hulten M, Orstavik KH, Reilly S, Cass H, Clarke A, Kerr AM, Bailey ME (2005) Dimensional phenotypic analysis and functional categorisation of mutations reveal novel genotype\u2013phenotype associations in Rett syndrome. Eur J Hum Genet 13:1121\u20131130","journal-title":"Eur J Hum Genet"},{"key":"585_CR9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/hmg\/9.7.1119","volume":"12","author":"JP Cheadle","year":"2000","unstructured":"Cheadle JP, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, Krawczak M, Cooper DN, Lynch S, Thomas N, Hughes H, Hulten M, Ravine D, Sampson JR, Clarke A (2000) Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet 12:1119\u20131129","journal-title":"Hum Mol Genet"},{"key":"585_CR10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/humu.10194","volume":"21","author":"J Christodoulou","year":"2003","unstructured":"Christodoulou J, Grimm A, Maher T, Bennetts B (2003) RettBASE: the IRSA MECP2 variation database\u2014a new mutation database in evolution. Hum Mutat 21:466\u2013472","journal-title":"Hum Mutat"},{"key":"585_CR11","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0140-6736(00)02661-1","volume":"356","author":"J Clayton-Smith","year":"2000","unstructured":"Clayton-Smith J, Watson P, Ramsden S, Black GC (2000) Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet 356:830\u2013832","journal-title":"Lancet"},{"key":"585_CR12","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","volume":"13","author":"AL Collins","year":"2004","unstructured":"Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, Noebels JL, David Sweatt J, Zoghbi HY (2004) Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13:2679\u20132689","journal-title":"Hum Mol Genet"},{"key":"585_CR13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/hmg\/10.9.941","volume":"10","author":"P Couvert","year":"2001","unstructured":"Couvert P, Bienvenu T, Aquaviva C, Poirier K, Moraine C, Gendrot C, Verloes A, Andr\u00e8s C, Le Fevre AC, Souville I, Steffann J, des Portes V, Ropers HH, Yntema HG, Fryns JP, Briault S, Chelly J, Cherif B (2001) MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet 10:941\u2013946","journal-title":"Hum Mol Genet"},{"key":"585_CR14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/01.gim.0000250502.28516.3c","volume":"8","author":"D del Gaudio","year":"2006","unstructured":"del Gaudio D, Fang P, Scaglia F, Ward PA, Craigen WJ, Glaze DG, Neul JL, Patel A, Lee JA, Irons M, Berry SA, Pursley AA, Grebe TA, Freedenberg D, Martin RA, Hsich GE, Khera JR, Friedman NR, Zoghbi HY, Eng CM, Lupski JR, Beaudet AL, Cheung SW, Roa BB (2006) Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Med 8:784\u2013792","journal-title":"Genet Med"},{"key":"585_CR15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1212\/WNL.58.2.226","volume":"22","author":"MT Dotti","year":"2002","unstructured":"Dotti MT, Orrico A, De Stefano N, Battisti C, Sicurelli F, Severi S, Lam CW, Galli L, Sorrentino V, Federico A (2002) A Rett syndrome MECP2 mutation that causes mental retardation in men. Neurology 22:226\u2013230","journal-title":"Neurology"},{"key":"585_CR16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/08830738050200090501","volume":"20","author":"A Erlandson","year":"2005","unstructured":"Erlandson A, Hagberg B (2005) MECP2 abnormality phenotypes: clinicopathologic area with broad variability. J Child Neurol 20:727\u2013732","journal-title":"J Child Neurol"},{"key":"585_CR17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/(SICI)1096-8628(19990423)83:5<411::AID-AJMG14>3.0.CO;2-B","volume":"23","author":"C Gendrot","year":"1999","unstructured":"Gendrot C, Ronce N, Raynaud M, Ayrault AD, Dourlens J, Castelnau P, Muh JP, Chelly J, Moraine C (1999) X-linked nonspecific mental retardation (MRX16) mapping to distal Xq28: linkage study and neuropsychological data in a large family. Am J Med Genet 23:411\u2013418","journal-title":"Am J Med Genet"},{"key":"585_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0887-8994(94)90082-5","volume":"11","author":"BA Hagberg","year":"1994","unstructured":"Hagberg BA, Skjeldal OH (1994) Rett variants: a suggested model for inclusion criteria. Pediatr Neurol 11:5\u201311","journal-title":"Pediatr Neurol"},{"key":"585_CR19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/ejpn.2002.0612","volume":"6","author":"B Hagberg","year":"2002","unstructured":"Hagberg B, Hanefeld F, Percy A, Skjeldal O (2002) An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. Eur J Paediatr Neurol 6:293\u2013297","journal-title":"Eur J Paediatr Neurol"},{"key":"585_CR20","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1212\/WNL.56.11.1486","volume":"56","author":"K Hoffbuhr","year":"2001","unstructured":"Hoffbuhr K, Devaney JM, LaFleur B, Sirianni N, Scacheri C, Giron J, Schuette J, Innis J, Marino M, Philippart M, Narayanan V, Umansky R, Kronn D, Hoffman EP, Naidu S (2001) MeCP2 mutations in children with and without the phenotype of Rett syndrome. Neurology 56:1486\u20131495","journal-title":"Neurology"},{"key":"585_CR23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/hmg\/9.9.1369","volume":"9","author":"P Huppke","year":"2000","unstructured":"Huppke P, Laccone F, Kr\u00e4mer N, Engel W, Hanefeld F (2000) Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet 9:1369\u20131375","journal-title":"Hum Mol Genet"},{"key":"585_CR21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/s-2002-32365","volume":"33","author":"P Huppke","year":"2002","unstructured":"Huppke P, Held M, Hanefeld F, Engel W, Laccone F (2002) Influence of mutation type and location on phenotype in 123 patients with Rett syndrome. Neuropediatrics 33:63\u201368","journal-title":"Neuropediatrics"},{"key":"585_CR22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejpn.2006.09.003","volume":"11","author":"P Huppke","year":"2007","unstructured":"Huppke P, K\u00f6hler K, Brockmann K, Stettner GM, G\u00e4rtner J (2007) Treatment of epilepsy in Rett syndrome. Eur J Pediatr Neurol 11:10\u201316","journal-title":"Eur J Pediatr Neurol"},{"key":"585_CR24","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/hmg\/ddn061","volume":"17","author":"B Kerr","year":"2008","unstructured":"Kerr B, Alvarez-Saavedra M, S\u00e1ez MA, Saona A, Young JI (2008) Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice. Hum Mol Genet 17:1707\u20131717","journal-title":"Hum Mol Genet"},{"key":"585_CR25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2008.04.058","volume":"589","author":"B Kim","year":"2008","unstructured":"Kim B, Rinc\u00f3n Castro LM, Jawed S, Niles LP (2008) Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells. Eur J Pharmacol 589:45\u201348","journal-title":"Eur J Pharmacol"},{"key":"585_CR26","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1086\/339553","volume":"70","author":"SM Klauck","year":"2002","unstructured":"Klauck SM, Lindsay S, Beyer KS, Splitt M, Burn J, Poustka A (2002) A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet 70:1034\u20131037","journal-title":"Am J Hum Genet"},{"key":"585_CR27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jmg.40.7.487","volume":"40","author":"S Kudo","year":"2003","unstructured":"Kudo S, Nomura Y, Segawa M, Fujita N, Nakao M, Schanen C, Tamura M (2003) Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. J Med Genet 40:487\u2013493","journal-title":"J Med Genet"},{"key":"585_CR28","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1242\/jcs.016865","volume":"121","author":"A Kumar","year":"2008","unstructured":"Kumar A, Kamboj S, Malone BM, Kudo S, Twiss JL, Czymmek KJ, Lasalle JM, Schanen NC (2008) Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J Cell Sci 121:1128\u20131137","journal-title":"J Cell Sci"},{"key":"585_CR29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/088307380101600505","volume":"16","author":"H Leonard","year":"2001","unstructured":"Leonard H, Silberstein J, Falk R, Houwink-Manville I, Ellaway C, Raffaele LS, Engerstr\u00f6m IW, Schanen C (2001) Occurrence of Rett syndrome in boys. J Child Neurol 16:333\u2013338","journal-title":"J Child Neurol"},{"key":"585_CR31","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/MCB.16.1.414","volume":"16","author":"X Nan","year":"1996","unstructured":"Nan X, Tate P, Li E, Bird A (1996) DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol 16:414\u2013421","journal-title":"Mol Cell Biol"},{"key":"585_CR30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","volume":"393","author":"X Nan","year":"1998","unstructured":"Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386\u2013389","journal-title":"Nature"},{"key":"585_CR32","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","volume":"70","author":"JL Neul","year":"2008","unstructured":"Neul JL, Fang P, Barrish J, Lane J, Caeg EB, Smith EO, Zoghbi H, Percy A, Glaze DG (2008) Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 70:1313\u20131321","journal-title":"Neurology"},{"key":"585_CR33","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","volume":"11","author":"PC Ng","year":"2001","unstructured":"Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11:863\u2013874","journal-title":"Genome Res"},{"key":"585_CR34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.ejhg.5200600","volume":"3","author":"JB Nielsen","year":"2001","unstructured":"Nielsen JB, Henriksen KF, Hansen C, Silahtaroglu A, Schwartz M, Tommerup N (2001) MECP2 mutations in Danish patients with Rett syndrome: high frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern. Eur J Hum Genet 3:178\u2013184","journal-title":"Eur J Hum Genet"},{"key":"585_CR35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-5793(00)01994-3","volume":"481","author":"A Orrico","year":"2000","unstructured":"Orrico A, Lam C, Galli L, Dotti MT, Hayek G, Tong SF, Poon PM, Zappella M, Federico A, Sorrentino V (2000) MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett 481:285\u2013288","journal-title":"FEBS Lett"},{"key":"585_CR36","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1093\/nar\/gkf493","volume":"30","author":"V Ramensky","year":"2002","unstructured":"Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894\u20133900","journal-title":"Nucleic Acids Res"},{"key":"585_CR37","doi-asserted-by":"crossref","unstructured":"Renieri A, Mari F, Mencarelli MA, Scala E, Ariani F, Longo I, Meloni I, Cevenini G, Pini G, Hayek G, Zappella M (2008) Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant). Brain Dev. doi: 10.1016\/j.braindev.2008.04.007","DOI":"10.1016\/j.braindev.2008.04.007"},{"key":"585_CR38","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/hmg\/ddn062","volume":"17","author":"RC Samaco","year":"2008","unstructured":"Samaco RC, Fryer JD, Ren J, Fyffe S, Chao HT, Sun Y, Greer JJ, Zoghbi HY, Neul JL (2008) A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum Mol Genet 17:1718\u20131727","journal-title":"Hum Mol Genet"},{"key":"585_CR39","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/ajmg.a.32002","volume":"143A","author":"E Scala","year":"2007","unstructured":"Scala E, Longo I, Ottimo F, Speciale C, Sampieri K, Katzaki E, Artuso R, Mencarelli MA, D\u2019Ambrogio T, Vonella G, Zappella M, Hayek G, Battaglia A, Mari F, Renieri A, Ariani F (2007) MECP2 deletions and genotype\u2013phenotype correlation in Rett syndrome. Am J Med Genet A 143A:2775\u20132784","journal-title":"Am J Med Genet A"},{"key":"585_CR40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.ejhg.5200745","volume":"10","author":"M Top\u00e7u","year":"2002","unstructured":"Top\u00e7u M, Akyerli C, Sayi A, T\u00f6r\u00fcner GA, Ko\u00e7o\u011flu SR, Cimbi\u015f M, Oz\u00e7elik T (2002) Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur J Hum Genet 10:77\u201381","journal-title":"Eur J Hum Genet"},{"key":"585_CR41","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1212\/WNL.55.8.1188","volume":"55","author":"L Villard","year":"2000","unstructured":"Villard L, Kpebe A, Cardoso C, Chelly PJ, Tardieu PM, Fontes M (2000) Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology 55:1188\u20131193","journal-title":"Neurology"},{"key":"585_CR42","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1086\/302690","volume":"65","author":"M Wan","year":"1999","unstructured":"Wan M, Lee SS, Zhang X, Houwink-Manville I, Song HR, Amir RE, Budden S, Naidu S, Pereira JL, Lo IF, Zoghbi HY, Schanen NC, Francke U (1999) Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 65:1520\u20131529","journal-title":"Am J Hum Genet"},{"key":"585_CR43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajmg.a.10053","volume":"118A","author":"LS Weaving","year":"2003","unstructured":"Weaving LS, Williamson SL, Bennetts B, Davis M, Ellaway CJ, Leonard H, Thong MK, Delatycki M, Thompson EM, Laing N, Christodoulou J (2003) Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. Am J Med Genet A 118A:103\u2013114","journal-title":"Am J Med Genet A"},{"key":"585_CR44","doi-asserted-by":"crossref","first-page":"19416","DOI":"10.1073\/pnas.0707442104","volume":"104","author":"DH Yasui","year":"2007","unstructured":"Yasui DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher KN, Farnham PJ, Lasalle JM (2007) Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA 104:19416\u201319421","journal-title":"Proc Natl Acad Sci USA"},{"key":"585_CR45","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1093\/nar\/28.21.4172","volume":"28","author":"TM Yusufzai","year":"2001","unstructured":"Yusufzai TM, Wolffe AP (2001) Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res 28:4172\u20134179","journal-title":"Nucleic Acids Res"},{"key":"585_CR46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ajmg.10005","volume":"104","author":"M Zappella","year":"2001","unstructured":"Zappella M, Meloni I, Longo I, Hayek G, Renieri A (2001) Preserved speech variants of the Rett syndrome: molecular and clinical analysis. Am J Med Genet 104:14\u201322","journal-title":"Am J Med Genet"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-008-0585-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00439-008-0585-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-008-0585-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:26:00Z","timestamp":1559071560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00439-008-0585-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,7]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["585"],"URL":"https:\/\/doi.org\/10.1007\/s00439-008-0585-6","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,7]]}}}